ISO 13485 certification is not a one-time achievement—it requires annual surveillance audits and a full recertification every three years. JiNDA Health Care has successfully completed its latest surveillance audit, maintaining full compliance with the international standard for medical device quality management systems. For B2B partners, this annual verification carries significant procurement implications that go beyond a certificate on file.
Surveillance audits examine whether a manufacturer’s documented processes align with actual production practices. Auditors review design control records, supplier qualification files, corrective and preventive action (CAPA) logs, and traceability documentation across the entire supply chain. A clean audit result confirms that the quality system is not merely theoretical—it is operational, enforced, and continuously improved. This distinguishes certified manufacturers from suppliers who hold certificates but operate with inconsistent quality controls.
For distributors and group purchasing organizations, an unbroken audit record simplifies vendor qualification. Many North American and European procurement frameworks require suppliers to demonstrate ongoing compliance, not just initial certification. GPOs, VA contracts, and state procurement programs frequently request the last surveillance audit date as part of their vendor assessment. A current, clean record eliminates a common compliance barrier and shortens the approval cycle.
JiNDA’s 18 years of manufacturing experience, combined with sustained ISO 13485 compliance, US local stock availability, and full OEM/ODM capabilities, provide the compliance and operational reliability that institutional buyers demand. Partners can request audit summary documentation and quality system records directly through the JiNDA B2B portal for their own vendor qualification files.